FreshPatents.com Logo


new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)


Similar
Filing Names

Incyte Corporation
Incyte Corporation A Delaware Corporation
Incyte Corporationn A Delaware Corporation

Popular
Companies


Web
Adobe patents
Akamai patents
Amazon patents
Apple patents
Ebay patents
Facebook patents
Google patents
IBM patents
Linkedin patents
Microsoft patents
Oracle patents
Red Hat patents
Yahoo patents

Food/Health
Adidas
Nike patents
Pfizer patents
Monsanto patents
Medtronic patents
Kraft patents

Transportation
Boeing patents
Tesla Motors patents

Telecom
Qualcomm patents
Motorola patents
Nokia patents
RIMM patents

Industrial/Electronics
AMD
Applied Materials
Seagate patents
General Electric
Caterpillar patents
Samsung
Wal-mart patents

Ticker Symbols

Incyte Corporation patents


      
Recent patent applications related to Incyte Corporation. Incyte Corporation is listed as an Agent/Assignee. Note: Incyte Corporation may have other listings under different names/spellings. We're not affiliated with Incyte Corporation, we're just tracking patents.

ARCHIVE: New 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Incyte Corporation-related inventors



Search recent Press Releases: Incyte Corporation-related press releases
Count Application # Date Incyte Corporation patents (updated weekly) - BOOKMARK this page
12010002252201/28/10Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
22014037121612/18/14 new patent  Purinone derivatives as hm74a agonists
32014034303011/20/14Bipyrazole derivatives as jak inhibitors
42014031596210/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase
52014027503009/18/14Tricyclic heterocycles as bet protein inhibitors
62014027503109/18/14Piperidin-4-yl azetidine derivatives as jak1 inhibitors
72014027512709/18/14Substituted heteroaryl fused derivatives as pi3k inhibitors
82014025694109/11/14Processes and intermediates for making a jak inhibitor
92014024913209/04/14Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
102014024208608/28/14Polynucleotides encoding signal peptide-containing molecules
112014024330808/28/14Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
122014024336008/28/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
132014022727508/14/14Methods of treating and diagnosing pancreatitis
142014022727808/14/14Antibodies to human signal peptide-containing proteins
152014022834608/14/14Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
162014022137908/07/14N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
172014020021607/17/14Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
182014020022707/17/14Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
192014018753007/03/14Aza spiro alkane derivatives as inhibitors of metalloproteases
202014017140506/19/14Fused pyrazoles as fgfr inhibitors
212014017140906/19/14Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
222014015528806/05/14Methods for diagnosing cancer
232014015537706/05/143-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
242014015540406/05/14Piperazinylpiperidine derivatives as chemokine receptor antagonists
252014013535005/15/14Sustained-release dosage forms of ruxolitinib
262014012119805/01/14Tricyclic fused thiophene derivatives as jak inhibitors
272014012122205/01/14Pyrimidinones as pi3k inhibitors
282014006644803/06/14Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
292014005690602/27/14Secreted proteins
302014005791202/27/14Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
312014004581402/13/14Pyrazine derivatives as fgfr inhibitors
322014003134401/30/14Azepine inhibitors of janus kinases
332014002366301/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
342014001837401/16/14Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
352014000516601/02/14Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
362014000521001/02/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
372013034515712/26/13Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
382013034522412/26/13Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
392013032451512/05/13Imidazotriazines and imidazopyrimidines as kinase inhibitors
402013025319009/26/13Processes for preparing jak inhibitors and related intermediate compounds
412013025319109/26/13Processes for preparing jak inhibitors and related intermediate compounds
422013025319309/26/13Processes for preparing jak inhibitors and related intermediate compounds
432013024378109/19/13Signal peptide-containing proteins
442013024492709/19/13Polynucleotides encoding signal peptide-containing molecules
452013024499909/19/13Substituted heterocyclic compounds
462013022476908/29/13Methods of using chemokine panec-1 antibodies
472013022555608/29/13Azetidine and cyclobutane derivatives as jak inhibitors
482013019025007/25/13Polynucleotides encoding human signal peptide-containing proteins
492013017759007/11/13N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
502013013768105/30/13Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
512013012324605/16/13Modulators of indoleamine 2,3-dioxygenase and methods of using the same
522013011623005/09/133-aminopyrrolidine derivatives as modulators of chemokine receptors
532013009614404/18/13Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
542013005894203/07/13Human beta-adrenergic receptor kinase polypeptide and methods
552013005983503/07/13Heterocyclylamines as pi3k inhibitors
562013006002603/07/13Processes and intermediates for making a jak inhibitor
572013004596302/21/13Cyclohexyl azetidine derivatives as jak inhibitors
582013001803401/17/13Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
592013001806801/17/13Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
602012032978212/27/12Azepine inhibitors of janus kinases
612012030146411/29/12Janus kinase inhibitors for treatment of dry eye and other eye related diseases
622012029591211/22/12Piperazinylpiperidine derivatives as chemokine receptor antagonists
632012027080910/25/12Human transmembrane proteins
642012012285805/17/12Lactam compounds and their use as pharmaceuticals
652012004096402/16/12N-substituted piperidines and their use as pharmaceuticals
662012003517202/09/12Purinone derivatives as hm74a agonists
672012001493701/19/12Human beta-adrenergic receptor kinase polypeptide and methods
682012001592801/19/12Amido compounds and their use as pharmaceuticals
692011025121510/13/11Macrocyclic compounds and their use as kinase inhibitors
702011021296709/01/11Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
712011020775408/25/11Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
722011013678106/09/11Imidazotriazines and imidazopyrimidines as kinase inhibitors
732011008681004/14/11Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
742011008215904/07/11Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
752011005321703/03/11Polynucleotides encoding signal peptide-containing molecules
762010027933311/04/10Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
772010025611410/07/10Amido compounds and their use as pharmaceuticals
782010024067109/23/10Substituted heterocyclic compounds
792010020303908/12/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
802010019080407/29/10Macrocyclic compounds and their use as kinase inhibitors
812010017390107/08/10Substituted heterocyclic compounds
822010013740106/03/102-methylprop anamides and their use as pharmaceuticals
832010011950305/13/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
842010009961704/22/10Secreted proteins
852009031840512/24/094-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
862009029194611/26/09Lactam compounds and their use as pharmaceuticals
872009028677411/19/09Purinone derivatives as hm74a agonists
882009028677811/19/09Macrocyclic compounds and their use as kinase inhibitors
892009027468011/05/09Human phospholipases
902009023390309/17/09Azetidine and cyclobutane derivatives as jak inhibitors
912009021576608/27/09Tetracyclic inhibitors of janus kinases
922009019788708/06/09Piperazinylpiperidine derivatives as chemokine receptor antagonists
932009018195907/16/09Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
942009012464905/14/09Aza spiro alkane derivatives as inhibitors of metalloproteases
952009008844604/02/09Purinone derivatives as hm74a agonists
962009007626903/19/09Purinone derivatives as hm74a agonists
972012026367610/18/12Compositions, methods and kits relating to her-2 cleavage
982012005807903/08/121,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
992012001498901/19/12Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1002011031147912/22/11Modulators of indoleamine 2,3-dioxygenase and methods of using the same
1012011022321009/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1022011022415709/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1032011017227907/14/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1042011016518807/07/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1052011008683504/14/11Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1062009029880812/03/09Inhibitors of 11-beta hydroxyl steroid dehydrogenase type i and methods of using the same
1072009019786908/06/09Azepine inhibitors of janus kinases


ARCHIVE: New 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Incyte Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Incyte Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###

     SHARE
  
         



Key IP Translations - Patent Translations